TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/8/24 17:04 | 3/6/24 | DVA | Davita Inc. | DE | Health | Health | Misc Health & Allied Services | Ackerman Joel | CO | O | CFO,Trea | M.d | 2,883 | 52.41 | 0 | 55 | 54 | 157 | D | ||||||||||||||
2/23/24 17:43 | 2/21/24 | DVA | Davita Inc. | DE | Health | Health | Misc Health & Allied Services | Ackerman Joel | CO | O | CFO,Trea | M.d | 2,883 | 52.41 | 0 | 55 | 64 | 140 | D | ||||||||||||||
1/5/24 15:52 | 10/17/23 | CSBR | Champions Oncology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ackerman Joel | NJ | D | M.d | 241 | 2.10 | 0 | 115 | 15 | 857 | D | |||||||||||||||
5/12/23 20:44 | 5/10/23 | DVA | Davita Inc. | DE | Health | Health | Misc Health & Allied Services | Ackerman Joel | CO | O | CFO,Trea | M.d | 3,733 | 66.29 | 0 | 56 | 64 | 144 | D | ||||||||||||||
10/20/22 13:26 | 10/19/22 | CSBR | Champions Oncology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ackerman Joel | NJ | D | M.d | 54 | 3.21 | 0 | 17 | 1 | 1,461 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |